Артракам is commonly used in the symptomatic management of degenerative joint conditions, primarily osteoarthritis (OA). The therapeutic use is relevant for easing symptoms related to mild to moderate osteoarthritis of the knee.

The medicine is commonly used to help with symptomatic relief in conditions presenting with systemic or localized discomfort, chronic joint stiffness, and reduced flexibility. This is relevant when supportive symptom management of chronic joint pain and functional impairment is appropriate. It helps address symptom clusters that may become intense or disruptive, such as persistent aching and the reduced range of motion often experienced upon rising. The medicine helps support the patient during difficult symptomatic phases, assisting with maintaining functional stability.

Long-Term Symptom Management

This block covers the primary application: providing sustained, therapeutic support for patients dealing with the symptoms related to physical discomfort of osteoarthritis, particularly in major joints like the knee, hip, and spine. It supports general well-being during symptomatic phases of long-term treatment and may assist with easing the overall burden of persistent discomfort. The medicine contributes to improved comfort and helps patients cope more steadily with the impact of chronic joint limitations.

Quick Fact: Relevant for Symptoms Related to Physical Discomfort

The official regulatory profile for Артракам (Glucosamine sulfate) clearly defines the populations eligible for use and those who are prohibited or restricted, based on labeling from national and European drug authorities.

Category	Eligibility Rule (Official Wording)
Allowed Population	Adults and the elderly with mild to moderate osteoarthritis of the knee.
Absolute Contraindications	Hypersensitivity to Glucosamine or excipients; patients with shellfish allergy due to the drug's origin.
Age-Related Rule	Should not be used in children and adolescents under 18 years.
Conditional Use / Caution	Patients with impaired glucose tolerance (e.g., diabetics) require closer monitoring of blood glucose levels.
Physiological Restrictions	Not recommended during pregnancy or lactation due to the lack of established safety data.
Organ Impairment	Patients with severe hepatic or renal insufficiency must use the medicine under medical supervision as specific dose recommendations are not established.

This regulatory framework establishes absolute non-eligibility through contraindications like allergies and limits use based on age, physiological states, and specific comorbidities. The eligible group is formally defined as healthy adults for the labeled indication, with all other groups subject to explicit prohibition or conditional use rules.

Interactions with other medicines and products

The official regulatory profile for Diacerein (Артракам) highlights interactions primarily related to gastrointestinal effects, systemic absorption, and hepatic risk. Patients must adhere to specific rules for co-administration to mitigate these risks.

Contraindicated and High-Risk Combinations

Classification	Interacting Entity	Constraint / Rationale
Contraindicated	Existing Liver Disease or History of Liver Disease	Prohibition of use in this patient population.
Avoid	Laxatives (All types)	Additive laxative effect increases risk of severe diarrhea and dehydration.
Caution	Diuretics (e.g., Thiazides) & Cardiac Glycosides	Diarrhea can cause hypokalemia, increasing the risk of cardiac arrhythmia.
Caution	Other Products Associated with Hepatic Injury	Increased risk of elevated liver enzymes or acute hepatic injury.

Absorption and Timing Requirements

Absorption of Diacerein is significantly reduced when taken with Antacids (containing aluminum, calcium, or magnesium compounds). To prevent this decrease in systemic exposure, Antacids must be administered separately, requiring a time interval of greater than 2 hours from the Diacerein dose. Additionally, the label advises that the drug's bioavailability is increased when taken with food.

Patients should also be advised to limit their alcohol intake while on treatment. Use in patients aged 65 years and above is not recommended due to a higher risk of severe diarrhea and associated complications.

How Артракам Works: Mechanism of Action

The biological effect of Glucosamine sulfate (Артракам) operates through a dual mechanistic influence: modulating catabolic pathways and providing necessary substrates for matrix synthesis. The mechanism inherently requires a sustained period due to its dependence on slow cellular metabolic turnover.

---

⌨️ Modulation of Catabolic and Inflammatory Signaling

The molecule functions as a signaling pathway modulator, primarily establishing an anti-catabolic effect. Glucosamine sulfate modulates the activity of the NF-κB transcription factor, which regulates the genetic instructions for destructive enzymes. By reducing NF-kappa B activity, the compound limits the production of Matrix Metalloproteinases (MMPs) and pro-inflammatory mediators like PGE2 and IL-1beta. This modulation influences the maintenance of the cartilage structure by reducing the enzyme-driven degradation of the joint matrix.

---

Precursor Role in Extracellular Matrix Synthesis

The secondary, complementary domain involves anabolic support via substrate provision. Glucosamine provides the essential amino sugar precursor required by Chondrocytes (cartilage cells) for the construction of key structural components. This substrate supply influences the synthesis of Proteoglycans ( Aggrecan) and Hyaluronic Acid, which are vital for the elasticity, shock-absorbing capacity, and hydration of articular cartilage. This action provides the necessary precursor for the continuous renewal and maintenance of structural components.

General Principles of Administration

The administration of Glucosamine sulfate, the active ingredient in Артракам, is strictly by the oral route. The standard dosing regimen for adults requires a total of 1500 mg per day. This total amount is typically administered as a single dose once daily, but specific formulations, such as lower-strength capsules, may necessitate a divided dose taken multiple times daily to achieve the same total daily amount.

Timing and Preparation

To ensure proper intake, the medicine is generally taken preferably at mealtimes. If the prescribed form is a powder for oral solution, the contents of the sachet must be fully dissolved in a glass of water before ingestion. For solid dosage forms, instructions specify that score lines on tablets, if present, are for ease of swallowing only and are not intended to divide the dose into equal parts.

Duration of Use and Re-evaluation

Due to its classification as a slow-acting agent, the medicine is not indicated for the treatment of acute painful symptoms. Users should understand that symptomatic relief may not be observed until after several weeks of treatment. If symptomatic relief is not apparent after a course of two to three months, the continued administration of the medicine must be re-evaluated. Data supports continuous administration for up to three years.

Population-Specific Use

Usage is restricted to the adult population and is not recommended for children or adolescents under 18 years due to a lack of established data. No specific dose adjustment is required for otherwise healthy older adults.

Артракам's active ingredient, Diacerein, is classified as a symptomatic slow-acting drug for osteoarthritis (SYSADOA). Research has focused on its effect on symptoms, joint function, and structural changes associated with knee and hip osteoarthritis (OA).

---

Symptomatic Efficacy

• Pain and Function: Randomized controlled trials (RCTs) indicate that Diacerein may provide a small to modest reduction in pain compared to a placebo, typically after a prolonged treatment period (months). Some evidence suggests its symptomatic effect is comparable to certain non-steroidal anti-inflammatory drugs (NSAIDs) after the initial month of therapy. However, the evidence regarding its benefit on physical function is less consistent.
• Carry-over Effect: Certain studies report a carry-over effect, where the symptomatic benefit may persist for several weeks to months after the treatment is discontinued.

---

Structural Outcomes

Clinical trials have also investigated Diacerein's influence on joint structure, often measured by changes in joint space narrowing (JSN) observed on X-rays. While some long-term studies suggest a potential slowing of JSN, particularly in hip OA, this effect is often noted as small and its overall clinical significance remains a topic of ongoing discussion in the medical community.

---

Safety and Tolerability

• Adverse Events: The most frequently reported adverse event in clinical trials is diarrhea, which is often transient and dose-dependent. Other gastrointestinal issues and skin reactions have also been observed.
• Monitoring: Given some uncommon reports of hepatobiliary disorders, monitoring of liver enzyme levels may be advised during use. Overall, its safety profile in the treatment of OA is considered by some to be favorable when compared to the potential gastrointestinal, cardiovascular, and renal risks associated with prolonged use of traditional NSAIDs.

Common questions about Артракам (FAQ)

---

Q: Does Артракам cause drowsiness or affect my ability to drive?

A: According to the official product information, side effects such as somnolence (drowsiness) are listed as common, and dizziness is listed as uncommon. Patients should be aware of these potential effects. If these effects occur, consult the official product information for guidance regarding activities like driving or operating machinery.

---

Q: Can Артракам interact with common blood thinners?

A: Yes, official regulatory documents state that Артракам is known to interact with certain coumarinic anticoagulants (medications often used as blood thinners, such as Warfarin). Because of this risk, starting or stopping Артракам therapy in combination with these anticoagulants typically requires closer medical monitoring of coagulation parameters (such as INR).

---

Q: Does Артракам affect blood sugar levels?

A: Caution is advised for people with impaired glucose tolerance or diabetes mellitus. Official product information for these patients advises that their blood glucose levels should be closely monitored during the course of treatment.

---

Q: Can people with liver conditions safely use Артракам?

A: No specific studies have been conducted in people with liver insufficiency. The product literature indicates that in cases of severe hepatic insufficiency (severe liver impairment), the use of the medicine is recommended only with appropriate medical supervision.

---

Q: Is it safe to use Артракам if I have high blood pressure?

A: In rare cases, an increase in blood pressure has been reported as an adverse effect. Additionally, patients with known risk factors for cardiovascular disease are advised to have their blood lipid levels monitored. If an individual has high blood pressure or known cardiovascular risk factors, they should discuss this with a healthcare professional to determine if monitoring is required.

---

Q: Are there special warnings for people with asthma using Артракам?

A: Yes, official warnings indicate that caution is required for patients with asthma. Reports have occasionally noted the possibility of an exacerbation (worsening) of asthma symptoms in some cases.

---

Q: What are the storage requirements for Артракам capsules/powder?

A: Official labeling states that the medicine must be stored at a temperature not exceeding 30 C and must be protected from moisture. It should be kept in the original package with the container tightly closed and stored out of the sight and reach of children.

---

Q: What happens if I forget to take a dose of Артракам?

A: If a dose is missed, it should be taken as soon as a patient remembers. However, if it is almost time for the next scheduled dose, the missed one should be skipped, and the regular schedule should be resumed. Official instructions specify that patients must not double the dose to make up for a missed one.

---

Q: Is it normal to have mild headaches when first taking Артракам?

Because: Yes, regulatory documents list headache as a Common side effect, meaning it may affect up to 1 in 10 people. Side effects reported with the medicine are generally described as mild and temporary.

---

Q: Is Артракам available over the counter, or is a prescription needed?

A: Артракам is classified as a pharmaceutical preparation. Its status as prescription-only or available over-the-counter (OTC) is determined by the specific regulatory authorization in your country and can vary by region.

---

Q: Are there common side effects I should watch out for when starting Артракам?

A: When starting treatment, the most frequently reported side effects (affecting up to 1 in 10 people) are typically related to the digestive system. These include diarrhea, nausea, abdominal pain, indigestion, and constipation, which are usually mild and temporary.

---

Q: Is it common to experience stomach upset with Артракам?

A: Gastrointestinal issues are among the most common side effects reported with the use of this medicine. Nausea, abdominal pain, and dyspepsia (indigestion) are listed in the Common category (may affect up to 1 in 10 people).

---

Q: Can I take Артракам if I also take a multivitamin?

A: While the official product information does not list specific interaction studies with multivitamins, patients should inform their healthcare professional of all supplements being taken, as is standard practice. There is a specific warning against taking the drug with antacids within two hours.

---

Q: Is it possible to be allergic to the inactive ingredients in Артракам?

A: Yes, the medicine is formally contraindicated in individuals with a known hypersensitivity not only to the active substance, Glucosamine sulfate, but also to any of the excipients (inactive ingredients) used in the formulation.

---

Q: What should I do if the side effects of Артракам are bothering me?

A: Official information advises that if side effects are bothersome or persistent, a patient should seek advice from a qualified healthcare professional. This ensures that the need for continued treatment can be evaluated safely.

---

Q: Are there specific patient groups who should absolutely avoid Артракам?

A: Yes, use is contraindicated for individuals with a known shellfish allergy (due to the drug's origin) or hypersensitivity to any component of the medicine. It is also officially not recommended for use in children, adolescents, or during pregnancy and lactation.

The storage and disposal of Артракам (Glucosamine sulfate) must adhere strictly to the conditions specified in official regulatory labeling to maintain stability.

Storage Requirements

Item	Requirement
Temperature	Store at a temperature not exceeding 30 C; refrigeration is not required.
Handling/Protection	Must be stored to protect from moisture.
Container Rule	Store in the original package and keep the container tightly closed.
In-Use Stability	For containers (not blisters), use within 6 months after first opening.
Child Safety	Keep the medicine out of the sight and reach of children.

Disposal Instructions

Unused or expired medicine must be disposed of according to local requirements for medicinal products. The product must not be thrown away via wastewater (flushed down the sink or toilet) or general household waste, following standard environmental guidance for pharmaceuticals. The FDA recommends using a drug take-back program when available.